US Oncology- Central Drug — Fort Worth, Texas

US Oncology- Central Drug is a clinical research site located in Fort Worth, Texas, United States 76177.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

US Oncology- Central Drug has participated in 1 clinical trials.

Therapeutic areas: Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL).

Sponsors: Millennium Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US Oncology- Central Drug?

US Oncology- Central Drug has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US Oncology- Central Drug conducted?

US Oncology- Central Drug has 1 clinical trials on record. Their work covers Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL).

Is US Oncology- Central Drug accredited by Crixeo Health?

US Oncology- Central Drug has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US Oncology- Central Drug?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.